RNA-based cancer vaccines have emerged as a revolutionary immunotherapy, fueled by advances in mRNA technology and personalized medicine. Recent clinical successes—including an mRNA-4157/pembrolizumab combo that cut melanoma recurrence risk by...

Matthias Magoola DEI Biopharma, Kampala, Uganda; dei@deigroupinternational.com Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed modern medicine, progressing from diabetes treatments to versatile therapeutics with applications across multiple medical specialties.This review examines...